Matthew Giles > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Matthew Giles
Position
Partner
Career
Matt Giles is a partner in the firm’s Business Law department. He is a member of the firm’s Private Investment Funds group, Real Estate Industry group, and Capital Markets practice. Matt’s practice includes real estate and private equity fund formation, domestic and international securities offerings, partnership and limited liability company law, and mergers and acquisitions, with a focus on REITs and real estate capital markets. His corporate practice also includes securities law compliance and private company representation.
Education
JD, 1999, Harvard Law School / BA, 1996, The University of Chicago
Lawyer Rankings
United States > Investment fund formation and management > Private equity funds (including venture capital)
Goodwin‘s ‘top notch’ private investment funds team covers the full spectrum of private investment fund types across various asset classes, where the team has a strong track record with real estate funds, where institutional and high net worth individual investors operating on a national and global level comprise their client base. Mandee Gruen chairs the team and a member of the firm’s real estate industry and ESG and impact practices, with these areas being a focus of her private funds work. Gruen is based in New York, as is John Ferguson, who similarly advises on real estate funds, alongside infrastructure, debt and credit, private equity and fund of funds, while Paul Verbesey is a key name in Washington DC and Matthew Giles and up-and-coming partner Lynette Elam are key names in in Boston. James Donohue left the firm in April 2024.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism